salsoline has been researched along with 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dostert, P; Hashizume, Y; Maruyama, W; Matsubara, K; Naoi, M; Sobue, G | 1 |
1 other study(ies) available for salsoline and 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline
| Article | Year |
|---|---|
A dopaminergic neurotoxin, 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl(R)salsolinol, and its oxidation product, 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion, accumulate in the nigro-striatal system of the human brain.
Topics: Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine Agents; Humans; Isoquinolines; Neurotoxins; Osmolar Concentration; Oxidation-Reduction; Salsoline Alkaloids; Stereoisomerism; Substantia Nigra; Tetrahydroisoquinolines; Tissue Distribution | 1997 |